These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 19825097)

  • 41. [Type IV hypersensitivity to intravesical mitomycin].
    Cao Avellaneda E; López López AI; Maluff Torres A; Jiménez RM; Escudero Bragante JF; López Cubillana P; Prieto González A; Pérez Albacete M
    Actas Urol Esp; 2005 Sep; 29(8):803. PubMed ID: 16304917
    [No Abstract]   [Full Text] [Related]  

  • 42. [Mitomycin-induced hemolytic uremia syndrome].
    Steffens F
    Dtsch Med Wochenschr; 2004 Jul; 129(27):1528; author reply 1528. PubMed ID: 15227598
    [No Abstract]   [Full Text] [Related]  

  • 43. [Calcified bladder lesions secondary to the instillation of mitomycin C].
    Megias Garrigós J; Pelluch Auladell A; Romero Pérez P; Fernandez García J; Gassó Matoses M; Sánchez Marcos M; Mira Llinarés A
    Arch Esp Urol; 1991 Nov; 44(9):1057-60. PubMed ID: 1807206
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disposition of mitomycin C after local intraarterial application.
    Theisohn M; Fischbach R; Joseph G; Biederbick W; Rump AF; Botvinik-Helling S; Bäcker A; Woschee U; Heindel W; Lackner K; Klaus W
    Int J Clin Pharmacol Ther; 1997 Feb; 35(2):72-6. PubMed ID: 9147712
    [No Abstract]   [Full Text] [Related]  

  • 45. Results of a randomized phase III trial of sequential intravesical therapy with mitomycin C and bacillus Calmette-Guerin versus mitomycin C alone in patients with superficial bladder cancer.
    Witjes JA; Caris CT; Mungan NA; Debruyne FM; Witjes WP
    J Urol; 1998 Nov; 160(5):1668-71; discussion 1671-2. PubMed ID: 9783928
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hyperbaric oxygen therapy for mitomycin C-induced scleral necrosis.
    Bayer A; Mutiu FM; Sobaci G
    Ophthalmic Surg Lasers; 2001; 32(6):490-3. PubMed ID: 11725777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comeoscleral perforation after pterygium excision and intraoperative mitomycin C.
    Dadeya S; Fatima S
    Ophthalmic Surg Lasers Imaging; 2003; 34(2):146-8. PubMed ID: 12665232
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is intravesical bacillus Calmette-Guérin better than mitomycin for intermediate-risk bladder cancer?
    Dalbagni G
    Eur Urol; 2009 Aug; 56(2):257-8; discussion 258-9. PubMed ID: 19427109
    [No Abstract]   [Full Text] [Related]  

  • 49. [Early postoperative mitomycin C instillation: when and how?].
    Traxer O; Gattegno B
    Prog Urol; 2004 Apr; 14(2):249-51. PubMed ID: 15217151
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hyperbaric oxygen therapy for mitomycin C-induced scleral necrosis.
    Bayer A; Mutlu FM; Sobaci G
    Ophthalmic Surg Lasers; 2002; 33(1):58-61. PubMed ID: 11820665
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Re: mitomycin-induced punctal stenosis.
    Goldstein DA; Tessler HH
    Am J Ophthalmol; 2004 Mar; 137(3):593; author reply 593. PubMed ID: 15013904
    [No Abstract]   [Full Text] [Related]  

  • 52. A rash decision?
    Law R; Ravi K; Alexander JA
    Gastroenterology; 2013 May; 144(5):884, 1158. PubMed ID: 23523684
    [No Abstract]   [Full Text] [Related]  

  • 53. Delayed tissue necrosis associated with mitomycin-C administration.
    Murakami Y; Shibata S; Koso S; Nagae S; Furue M
    J Dermatol; 2000 Jun; 27(6):413-5. PubMed ID: 10920591
    [No Abstract]   [Full Text] [Related]  

  • 54. Erythroderma as drug eruption induced by intravesical mitomycin C therapy.
    Igawa K; Konishi M; Moriyama Y; Fukuyama K; Yokozeki H
    J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):613-4. PubMed ID: 24612357
    [No Abstract]   [Full Text] [Related]  

  • 55. [What we can learn from a case of medical malpractice].
    Kato S; Kobayashi H; Makita S; Kuwabara H
    Nihon Geka Gakkai Zasshi; 2005 Apr; 106(4):320. PubMed ID: 15859146
    [No Abstract]   [Full Text] [Related]  

  • 56. Interstitial pneumonitis and myelosuppression associated to mitomycin C urinary tract instillations: A case report.
    Rodriguez-Reyes M; Marco-Hernandez J; Castro-Rebollo P; Soy-Muner D
    J Oncol Pharm Pract; 2019 Apr; 25(3):739-742. PubMed ID: 29475405
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Parapelvic Dystrophic Calcification as a Result of Mitomycin C Extravasation.
    Leong JY; Teplitsky S; Han TM; Shah M; Chandrasekar T; Mann M
    Urology; 2020 Feb; 136():e34-e36. PubMed ID: 31545967
    [No Abstract]   [Full Text] [Related]  

  • 58. Distant and delayed mitomycin C extravasation.
    Patel JS; Krusa M
    Pharmacotherapy; 1999 Aug; 19(8):1002-5. PubMed ID: 10453974
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Mitomycin-induced pulmonary veno-occlusive disease: A rare but severe complication].
    Montani D; Chaumais MC; Seferian A; Humbert M
    Bull Cancer; 2017 Feb; 104(2):202-204. PubMed ID: 27884394
    [No Abstract]   [Full Text] [Related]  

  • 60. Response to Letter Regarding Article, "Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Model".
    Perros F; Günther S; Ranchoux B; Godinas L; Antigny F; Chaumais MC; Dorfmüller P; Hautefort A; Raymond N; Savale L; Jaïs X; Girerd B; Cottin V; Sitbon O; Simonneau G; Humbert M; Montani D
    Circulation; 2016 Apr; 133(14):e592-3. PubMed ID: 27045136
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.